Drug Trial Radar · NCT06833788
Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,860
Planned (sponsor's estimate)
Start
Oct 22, 2025
Primary completion
Jun 22, 2028
Study completion Oct 30, 2028
Sponsor
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectif of the IRON-DEP Study is to assess the efficacy of intravenous (IV) versus oral iron treatment on the prevalence of postpartum depression (PPD) in women with moderate iron deficiency anemia after caesarean delivery.
Conditions
- Postpartum Depression (PPD)
Interventions
Ferric carboxymaltose IVDrug
Single dose of Ferric carboxymaltose 1000 mg (20mL) IV infusion (20ml vial of 1000mg iron or two 10ml vials of 500mg)
TIMOFÉROL®Drug
100 mg once a day (2 pills of TIMOFÉROL® 50mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevalence of PostPartum Depression (PPD) symptoms defined by an Edinburg Postpartum Depression Scale (EPDS) score ≥ 11Time frame: 8 weeks postpartum
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHU Armand -Trousseau, AP-HP Service d'anesthésie-réanimation chirurgicale
Paris, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.